Cost-effectiveness of genome-guided statin treatment for hypercholesterolemia

Pharmacogenomics J. 2026 Jun 6;26(3):25. doi: 10.1038/s41397-026-00419-z.ABSTRACTCardiovascular disease and hypercholesterolemia present significant global health and economic burdens. While statins are the standard treatment, individual variability and toxicities necessitate personalized approaches

M Margarita-Ioanna Koufaki

Impact of hemoglobin glycation index and stress hyperglycemia ratio on short-term mortality in critically ill patients with heart failure: a retrospective cohort study using the MIMIC database

Nutr Metab Cardiovasc Dis. 2026 May 27:104814. doi: 10.1016/j.numecd.2026.104814. Online ahead of print.ABSTRACTBACKGROUND AND AIMS: To evaluate the prognostic value of the combined assessment of hemoglobin glycation index (HGI) and stress hyperglycemia ratio (SHR) for short-term mortality in critic

M Min He

Exploration of 3D fetal cardiac MRI in the late second trimester

J Cardiovasc Magn Reson. 2026 Jun 5:102754. doi: 10.1016/j.jocmr.2026.102754. Online ahead of print.ABSTRACTBACKGROUND: Fetal cardiovascular magnetic resonance imaging (CMR) is restricted to late gestation due to fetal movement and vessel size while initial clinical assessment of the fetal heart is

M Milou Pm van Poppel